Antimicrobial peptides: key components of the innate immune system
暂无分享,去创建一个
[1] Marc Torrent,et al. Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model , 2011, PloS one.
[2] Bono Lučić,et al. Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides , 2011, European Biophysics Journal.
[3] S. Myung,et al. Expression of human β‐defensin‐2 in the prostate , 2011, BJU international.
[4] R. Hancock,et al. Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli , 2010, Peptides.
[5] Shuang-quan Zhang,et al. Expression and purification of moricin CM4 and human β-defensins 4 in Escherichia coli using a new technology. , 2010, Microbiological research.
[6] Seong-Cheol Park,et al. Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis. , 2010, Biochemical and biophysical research communications.
[7] S. K. Shukla,et al. Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. , 2010, Biochimie.
[8] J. Wiesner,et al. Antimicrobial peptides: The ancient arm of the human immune system , 2010, Virulence.
[9] Chun Xing Li,et al. Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. , 2010, Developmental and comparative immunology.
[10] Y. Chuang,et al. In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrug-resistant Enterobacter cloacae. , 2010, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[11] Themis Lazaridis,et al. Antimicrobial peptides bind more strongly to membrane pores. , 2010, Biochimica et biophysica acta.
[12] Themis Lazaridis,et al. Antimicrobial peptides in toroidal and cylindrical pores. , 2010, Biochimica et biophysica acta.
[13] A. Schmidtchen,et al. C-terminal Peptides of Tissue Factor Pathway Inhibitor Are Novel Host Defense Molecules* , 2010, The Journal of Biological Chemistry.
[14] Shuang-quan Zhang,et al. Production of Bioactive Human Beta-Defensin-4 in Escherichia coli Using SUMO Fusion Partner , 2010, The protein journal.
[15] R. Epand,et al. Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline states in the presence of phosphatidylglycerol: lipid clustering in anionic membranes. , 2010, Biophysical journal.
[16] M. Cassone,et al. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics , 2010, Expert review of anti-infective therapy.
[17] Giacomo Mancini,et al. The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice , 2010, The Journal of Neuroscience.
[18] W. Shi,et al. Systematic Approach to Optimizing Specifically Targeted Antimicrobial Peptides against Streptococcus mutans , 2010, Antimicrobial Agents and Chemotherapy.
[19] D. Andersson,et al. Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2. , 2010, The Journal of antimicrobial chemotherapy.
[20] A. Schmidtchen,et al. Proteolysis of Human Thrombin Generates Novel Host Defense Peptides , 2010, PLoS pathogens.
[21] Diarmaid Hughes,et al. Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.
[22] Shunyi Zhu,et al. Antimicrobial peptide-like genes in Nasonia vitripennis: a genomic perspective , 2010, BMC Genomics.
[23] J. Schröder,et al. Increased expression of human beta‐defensin 3 in mollusca contagiosum , 2010, Clinical and experimental dermatology.
[24] Yoshiaki Nakagawa,et al. A Novel Amphipathic Linear Peptide with Both Insect Toxicity and Antimicrobial Activity from the Venom of the Scorpion Isometrus maculatus , 2010, Bioscience, biotechnology, and biochemistry.
[25] Y. Kato,et al. An enhancer peptide for membrane-disrupting antimicrobial peptides , 2010, BMC Microbiology.
[26] S. Rodziewicz-Motowidło,et al. Antimicrobial and conformational studies of the active and inactive analogues of the protegrin‐1 peptide , 2010, The FEBS journal.
[27] Yi Liu,et al. Design, Recombinant Expression, and Antibacterial Activity of the Cecropins–Melittin Hybrid Antimicrobial Peptides , 2010, Current Microbiology.
[28] K. Leszczynska,et al. Cathelicidin LL-37: A Multitask Antimicrobial Peptide , 2010, Archivum Immunologiae et Therapiae Experimentalis.
[29] F. Schweizer,et al. Cationic amphiphilic peptides with cancer-selective toxicity. , 2009, European journal of pharmacology.
[30] J. Bang,et al. Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1 , 2009, Peptides.
[31] D. Phoenix,et al. Anionic antimicrobial peptides from eukaryotic organisms. , 2009, Current protein & peptide science.
[32] Shreyas Karnik,et al. CAMP: a useful resource for research on antimicrobial peptides , 2009, Nucleic Acids Res..
[33] Constance Auvynet,et al. Multifunctional host defense peptides: Antimicrobial peptides, the small yet big players in innate and adaptive immunity , 2009, The FEBS journal.
[34] A. Schmidtchen,et al. Antimicrobial Activity of Human Prion Protein Is Mediated by Its N-Terminal Region , 2009, PloS one.
[35] L. Travassos,et al. Antifungal and antitumor models of bioactive protective peptides. , 2009, Anais da Academia Brasileira de Ciencias.
[36] A. Schmidtchen,et al. Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa. , 2009, Biochimica et biophysica acta.
[37] L. Babiuk,et al. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. , 2009, Vaccine.
[38] A. Schmidtchen,et al. Antimicrobial activity of a C-terminal peptide from human extracellular superoxide dismutase , 2009, BMC Research Notes.
[39] Aline Sandouk,et al. Role of acetylation and charge in antimicrobial peptides based on human β‐defensin‐3 , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[40] M. Palma,et al. Interactions of mast cell degranulating peptides with model membranes: a comparative biophysical study. , 2009, Archives of biochemistry and biophysics.
[41] P. Zipfel,et al. Complement Activation Products C3a and C4a as Endogenous Antimicrobial Peptides , 2009, International Journal of Peptide Research and Therapeutics.
[42] A. Schmidtchen,et al. Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags* , 2009, The Journal of Biological Chemistry.
[43] Huey W. Huang. Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides. , 2009, Biophysical journal.
[44] A. Schmidtchen,et al. End-Tagging of Ultra-Short Antimicrobial Peptides by W/F Stretches to Facilitate Bacterial Killing , 2009, PloS one.
[45] J. Bosch,et al. Concentration and fate of histatins and acidic proline-rich proteins in the oral environment. , 2009, Archives of oral biology.
[46] S. González-Chávez,et al. Lactoferrin: structure, function and applications. , 2009, International journal of antimicrobial agents.
[47] W. Yang,et al. Characterization of a novel antibacterial glycopeptide produced by Penicillium sp. M03 , 2009, Letters in applied microbiology.
[48] L. Babiuk,et al. The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice. , 2009, Vaccine.
[49] L. Babiuk,et al. Strategies to link innate and adaptive immunity when designing vaccine adjuvants. , 2009, Veterinary immunology and immunopathology.
[50] R. Gallo,et al. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. , 2009, Trends in immunology.
[51] M. N. Melo,et al. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations , 2009, Nature Reviews Microbiology.
[52] A. Figueras,et al. Evidence of high individual diversity on myticin C in mussel (Mytilus galloprovincialis). , 2009, Developmental and comparative immunology.
[53] Y. Guéguen,et al. Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin. , 2009, Molecular immunology.
[54] R. Hodges,et al. Influence of preformed α-helix and α-helix induction on the activity of cationic antimicrobial peptides , 2009 .
[55] R. Hancock,et al. The roles of cathelicidin LL-37 in immune defences and novel clinical applications , 2009, Current opinion in hematology.
[56] A. McDermott. The Role of Antimicrobial Peptides at the Ocular Surface , 2008, Ophthalmic Research.
[57] J. Potempa,et al. Corruption of Innate Immunity by Bacterial Proteases , 2008, Journal of Innate Immunity.
[58] Robert E W Hancock,et al. Effects of Hydrophobicity on the Antifungal Activity of α‐Helical Antimicrobial Peptides , 2008, Chemical biology & drug design.
[59] A. Schmidtchen,et al. Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37 , 2008, Antimicrobial Agents and Chemotherapy.
[60] T. Dandekar,et al. New trends in pharmacogenomic strategies against resistance development in microbial infections. , 2008, Pharmacogenomics.
[61] M. Leippe,et al. Hydramacin-1, Structure and Antibacterial Activity of a Protein from the Basal Metazoan Hydra* , 2008, Journal of Biological Chemistry.
[62] S. C. Kim,et al. Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. , 2008, Cancer letters.
[63] E. Veerman,et al. Histatins are the major wound‐closure stimulating factors in human saliva as identified in a cell culture assay , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] Xia Li,et al. APD2: the updated antimicrobial peptide database and its application in peptide design , 2008, Nucleic Acids Res..
[65] M. Selsted,et al. Isolation, Synthesis, and Antimicrobial Activities of Naturally Occurring θ-Defensin Isoforms from Baboon Leukocytes , 2008, Infection and Immunity.
[66] Yun Zhang,et al. Identification and characterization of novel reptile cathelicidins from elapid snakes , 2008, Peptides.
[67] Hailong Yang,et al. Snake Cathelicidin from Bungarus fasciatus Is a Potent Peptide Antibiotics , 2008, PloS one.
[68] A. N. Larsen,et al. Identification, cloning and expression analysis of a hepcidin cDNA of the Atlantic cod (Gadus morhua L.). , 2008, Fish & shellfish immunology.
[69] H. Naderi-manesh,et al. PCR-based Gene Synthesis, Molecular Cloning, High Level Expression, Purification, and Characterization of Novel Antimicrobial Peptide, Brevinin-2R, in Escherichia Coli , 2008, Applied biochemistry and biotechnology.
[70] A. Schmidtchen,et al. Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. , 2008, Biochemistry.
[71] Martin Malmsten,et al. Histidine-Rich Glycoprotein Protects from Systemic Candida Infection , 2008, PLoS pathogens.
[72] H. Khandelia,et al. The impact of peptides on lipid membranes. , 2008, Biochimica et biophysica acta.
[73] Yiannis N. Kaznessis,et al. Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: Predicting experimental toxicity , 2008, Peptides.
[74] M. Ward,et al. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. , 2008, The Journal of infectious diseases.
[75] H. Benson,et al. Skin peptides: biological activity and therapeutic opportunities. , 2008, Journal of pharmaceutical sciences.
[76] D. Andersson,et al. Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2 , 2008, Antimicrobial Agents and Chemotherapy.
[77] E. Veerman,et al. Human antimicrobial peptide histatin 5 is a cell‐ penetrating peptide targeting mitochondrial ATP synthesis in Leishmania , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[78] S. Qian,et al. Structure of the alamethicin pore reconstructed by x-ray diffraction analysis. , 2008, Biophysical journal.
[79] Shengwang Liu,et al. Expression and characterization of recombinant gallinacin-9 and gallinacin-8 in Escherichia coli. , 2008, Protein expression and purification.
[80] T. K. Maiti,et al. Targeting tumors with peptides from natural sources. , 2008, Trends in biotechnology.
[81] G. A. Somkuti,et al. Cloning of milk-derived bioactive peptides in Streptococcus thermophilus , 2008, Biotechnology Letters.
[82] S. C. Kim,et al. High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage , 2008, Applied Microbiology and Biotechnology.
[83] D. Hoskin,et al. Studies on anticancer activities of antimicrobial peptides. , 2008, Biochimica et biophysica acta.
[84] W. Florio,et al. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 , 2008, Peptides.
[85] Artem Cherkasov,et al. QSAR modeling and computer‐aided design of antimicrobial peptides , 2008, Journal of peptide science : an official publication of the European Peptide Society.
[86] M. Torres,et al. Expression of Cathelicidin LL-37 during Mycobacterium tuberculosis Infection in Human Alveolar Macrophages, Monocytes, Neutrophils, and Epithelial Cells , 2007, Infection and Immunity.
[87] M. Selsted,et al. Microbicidal Properties and Cytocidal Selectivity of Rhesus Macaque Theta Defensins , 2007, Antimicrobial Agents and Chemotherapy.
[88] A. Magill,et al. Application of 3D-QSAR for identification of descriptors defining bioactivity of antimicrobial peptides. , 2007, Journal of medicinal chemistry.
[89] D. Sturdevant,et al. The antimicrobial peptide‐sensing system aps of Staphylococcus aureus , 2007, Molecular microbiology.
[90] Barrie Wilkinson,et al. Drug discovery beyond the 'rule-of-five'. , 2007, Current opinion in biotechnology.
[91] R. Hancock,et al. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria , 2007, Expert review of anti-infective therapy.
[92] A. Schmidtchen,et al. Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. , 2007, Biochimica et biophysica acta.
[93] R. Hancock. The complexities of antibiotic action , 2007, Molecular systems biology.
[94] Y. Shai,et al. Conolysin-Mt: a conus peptide that disrupts cellular membranes. , 2007, Biochemistry.
[95] J. Willey,et al. Lantibiotics: peptides of diverse structure and function. , 2007, Annual review of microbiology.
[96] A. Telenti,et al. Innate immunogenetics: a tool for exploring new frontiers of host defence , 2007, The Lancet Infectious Diseases.
[97] V. Nizet. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. , 2007, The Journal of allergy and clinical immunology.
[98] D. Sturdevant,et al. Gram-positive three-component antimicrobial peptide-sensing system , 2007, Proceedings of the National Academy of Sciences.
[99] G. Pirri,et al. Antimicrobial peptides: an overview of a promising class of therapeutics , 2007, Central European Journal of Biology.
[100] K. Sayama,et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. , 2007, The Journal of investigative dermatology.
[101] R. Hancock,et al. Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections , 2007, Cellular and Molecular Life Sciences.
[102] R. Kini,et al. Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. , 2007, The Biochemical journal.
[103] R. Lehrer,et al. The innate immune system: a repository for future drugs? , 2007, Expert review of anti-infective therapy.
[104] I. Nagaoka,et al. Antimicrobial peptides human β‐defensin (hBD)‐3 and hBD‐4 activate mast cells and increase skin vascular permeability , 2007, European journal of immunology.
[105] A. Schmidtchen,et al. Preservation of Antimicrobial Properties of Complement Peptide C3a, from Invertebrates to Humans* , 2007, Journal of Biological Chemistry.
[106] Björn Walse,et al. Antimicrobial peptides derived from growth factors , 2007, Growth factors.
[107] A. Schmidtchen,et al. Histidine‐rich glycoprotein exerts antibacterial activity , 2007, The FEBS journal.
[108] D. Sturdevant,et al. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci , 2007, Molecular microbiology.
[109] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[110] M. Malmsten,et al. The contact system—a novel branch of innate immunity generating antibacterial peptides , 2006, The EMBO journal.
[111] M. Hamann,et al. Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. , 2006, Journal of natural products.
[112] G. Asensio,et al. The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity. , 2006, Bioorganic & medicinal chemistry.
[113] R. Hancock,et al. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. , 2006, Current opinion in pharmacology.
[114] Y. Shai,et al. A Synergism between Temporins toward Gram-negative Bacteria Overcomes Resistance Imposed by the Lipopolysaccharide Protective Layer* , 2006, Journal of Biological Chemistry.
[115] V. Kokryakov,et al. Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins. , 2006, Biochemical and biophysical research communications.
[116] K. Dyer,et al. The RNase a superfamily: Generation of diversity and innate host defense , 2006, Molecular Diversity.
[117] Vladimir Frecer,et al. QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1. , 2006, Bioorganic & medicinal chemistry.
[118] Ayyalusamy Ramamoorthy,et al. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. , 2006, Biochimica et biophysica acta.
[119] M. Yeaman,et al. Structural congruence among membrane-active host defense polypeptides of diverse phylogeny. , 2006, Biochimica et biophysica acta.
[120] K. Henzler-Wildman,et al. Expression and purification of a recombinant LL-37 from Escherichia coli. , 2006, Biochimica et biophysica acta.
[121] Huey W. Huang. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. , 2006, Biochimica et biophysica acta.
[122] V. Everts,et al. Role of Polymorphonuclear Leukocyte-Derived Serine Proteinases in Defense against Actinobacillus actinomycetemcomitans , 2006, Infection and Immunity.
[123] Alessandro Tossi,et al. Evolution of the Primate Cathelicidin , 2006, Journal of Biological Chemistry.
[124] R. Hancock,et al. Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.
[125] H. Sahl,et al. The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.
[126] Olivier Taboureau,et al. Design of Novispirin Antimicrobial Peptides by Quantitative Structure–Activity Relationship , 2006, Chemical biology & drug design.
[127] D. Hoover,et al. Human β-defensins , 2006, Cellular and Molecular Life Sciences CMLS.
[128] J. Malm,et al. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin. A NOVEL MECHANISM OF GENERATING ANTIMICROBIAL PEPTIDES IN VAGINA. VOLUME 278 (2003) PAGES 28540-28546 , 2006, Journal of Biological Chemistry.
[129] P. Yu,et al. Identification of three novel ostricacins: an update on the phylogenetic perspective of β-defensins , 2006 .
[130] S. Fernando,et al. Identification and Functional Characterization of Three Chicken Cathelicidins with Potent Antimicrobial Activity* , 2006, Journal of Biological Chemistry.
[131] Graham Bell,et al. Experimental evolution of resistance to an antimicrobial peptide , 2006, Proceedings of the Royal Society B: Biological Sciences.
[132] V. Nizet,et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[133] T. Cleveland,et al. Plant-derived antifungal proteins and peptides. , 2005, Canadian journal of microbiology.
[134] M. B. Banaszak Holl,et al. Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. , 2005, Biophysical journal.
[135] I. Nagaoka,et al. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. , 2005, Journal of dermatological science.
[136] G. J. Swaminathan,et al. Eosinophil-granule major basic protein, a C-type lectin, binds heparin. , 2005, Biochemistry.
[137] P. Valenti,et al. Lactoferrin , 2005, Cellular and Molecular Life Sciences.
[138] R. Shaykhiev,et al. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[139] Gifford Jl,et al. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. , 2005 .
[140] M. Hulett,et al. Histidine-rich Glycoprotein Specifically Binds to Necrotic Cells via Its Amino-terminal Domain and Facilitates Necrotic Cell Phagocytosis* , 2005, Journal of Biological Chemistry.
[141] A. Schmidtchen,et al. Domain 5 of High Molecular Weight Kininogen Is Antibacterial* , 2005, Journal of Biological Chemistry.
[142] Olivier Taboureau,et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus , 2005, Nature.
[143] C. Deber,et al. Basis for Selectivity of Cationic Antimicrobial Peptides for Bacterial Versus Mammalian Membranes* , 2005, Journal of Biological Chemistry.
[144] A. Yoshimura,et al. Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-371 , 2005, The Journal of Immunology.
[145] Roland Contreras,et al. Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins , 2005, Biotechnology Letters.
[146] Z. Figaszewski,et al. Changes in electric charge and phospholipids composition in human colorectal cancer cells , 2005, Molecular and Cellular Biochemistry.
[147] E. Veldhuizen,et al. CMAP27, a novel chicken cathelicidin-like antimicrobial protein. , 2005, Veterinary immunology and immunopathology.
[148] M. Andrés,et al. Different Anti-Candida Activities of Two Human Lactoferrin-Derived Peptides, Lfpep and Kaliocin-1 , 2005, Antimicrobial Agents and Chemotherapy.
[149] Y. Shai,et al. pH-dependent antifungal lipopeptides and their plausible mode of action. , 2005, Biochemistry.
[150] B. Meyer,et al. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. , 2005, Biochemistry.
[151] H. Vogel,et al. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin , 2005, Journal of peptide science : an official publication of the European Peptide Society.
[152] M. Selsted,et al. Mammalian defensins in the antimicrobial immune response , 2005, Nature Immunology.
[153] R. Hancock,et al. Immunomodulatory Activities of Small Host Defense Peptides , 2005, Antimicrobial Agents and Chemotherapy.
[154] M. Hulett,et al. Histidine‐rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems , 2005, Immunology and cell biology.
[155] D. Davidson,et al. Impact of LL‐37 on anti‐infective immunity , 2005, Journal of leukocyte biology.
[156] R. Hancock. Mechanisms of action of newer antibiotics for Gram-positive pathogens. , 2005, The Lancet. Infectious diseases.
[157] D. Hultmark,et al. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. , 2005, European journal of biochemistry.
[158] Y. Kaznessis,et al. Protegrin structure–activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity , 2005, Peptides.
[159] M. Zanetti,et al. The cathelicidins--structure, function and evolution. , 2005, Current protein & peptide science.
[160] Robert E W Hancock,et al. A re-evaluation of the role of host defence peptides in mammalian immunity. , 2005, Current protein & peptide science.
[161] E. Romanowski,et al. A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs , 2005, Current eye research.
[162] Yufeng Yao,et al. A Crucial Role for Exopolysaccharide Modification in Bacterial Biofilm Formation, Immune Evasion, and Virulence* , 2004, Journal of Biological Chemistry.
[163] L. Björck,et al. α2-Macroglobulin-Proteinase Complexes Protect Streptococcus pyogenes from Killing by the Antimicrobial Peptide LL-37* , 2004, Journal of Biological Chemistry.
[164] W. Shafer,et al. Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases , 2004, Antimicrobial Agents and Chemotherapy.
[165] C. Aranha,et al. Antimicrobial peptides: premises and promises. , 2004, International journal of antimicrobial agents.
[166] Artur,et al. Activation of the complement system generates antibacterial peptides , 2004 .
[167] M. Dathe,et al. Antimicrobial activity of arginine- and tryptophan-rich hexapeptides: the effects of aromatic clusters, D-amino acid substitution and cyclization. , 2004, The journal of peptide research : official journal of the American Peptide Society.
[168] M. Buschle,et al. The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens. , 2004, Vaccine.
[169] G. Zheng,et al. Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli. , 2004, Protein expression and purification.
[170] B. Ho,et al. De Novo Design of Potent Antimicrobial Peptides , 2004, Antimicrobial Agents and Chemotherapy.
[171] D. Shaw,et al. Peptides Derived from the Histidine-Proline Domain of the Histidine-Proline-Rich Glycoprotein Bind to Tropomyosin and Have Antiangiogenic and Antitumor Activities , 2004, Cancer Research.
[172] W. Kamysz,et al. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. , 2004, The Journal of infectious diseases.
[173] Gaetano T Montelione,et al. Cold-shock induced high-yield protein production in Escherichia coli , 2004, Nature Biotechnology.
[174] M. Dathe,et al. Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides. , 2004, Biochemistry.
[175] P. F. Almeida,et al. Kinetics of Dye Efflux and Lipid Flip-Flop Induced by δ-Lysin in Phosphatidylcholine Vesicles and the Mechanism of Graded Release by Amphipathic, α-Helical Peptides† , 2004 .
[176] J. Svendsen,et al. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins , 2004, Journal of peptide science : an official publication of the European Peptide Society.
[177] Yun-Bae Kim,et al. Helix Stability Confers Salt Resistance upon Helical Antimicrobial Peptides* , 2004, Journal of Biological Chemistry.
[178] J. Clifford,et al. Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis , 2004, Cancer Research.
[179] Zhenjun Sun,et al. Purification of a novel antibacterial short peptide in earthworm Eisenia foetida. , 2004, Acta biochimica et biophysica Sinica.
[180] D. Hoover,et al. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. , 2004, Annual review of immunology.
[181] K. Kavanagh,et al. Histatins: antimicrobial peptides with therapeutic potential , 2004, The Journal of pharmacy and pharmacology.
[182] A. Schmidtchen,et al. Antimicrobial activities of heparin-binding peptides. , 2004, European journal of biochemistry.
[183] Michael Otto,et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system , 2004, Cellular microbiology.
[184] F. Ge,et al. Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization. , 2004, Journal of biochemistry.
[185] A. Olsson,et al. A Fragment of Histidine-Rich Glycoprotein Is a Potent Inhibitor of Tumor Vascularization , 2004, Cancer Research.
[186] M. Zanetti. Cathelicidins, multifunctional peptides of the innate immunity , 2004, Journal of leukocyte biology.
[187] G. Arenas,et al. Antimicrobial peptides: A natural alternative to chemical antibiotics and a potential for applied biotechnology , 2003 .
[188] J. Cronan. Bacterial membrane lipids: where do we stand? , 2003, Annual review of microbiology.
[189] R. Hancock,et al. Structure-based design of an indolicidin peptide analogue with increased protease stability. , 2003, Biochemistry.
[190] P. McCray,et al. Antimicrobial peptides in animals and their role in host defences. , 2003, International journal of antimicrobial agents.
[191] M. Zasloff,et al. Hagfish intestinal antimicrobial peptides are ancient cathelicidins , 2003, Peptides.
[192] R. Hancock,et al. The relationship between peptide structure and antibacterial activity , 2003, Peptides.
[193] Webb Miller,et al. Multispecies comparative analysis of a mammalian-specific genomic domain encoding secretory proteins. , 2003, Genomics.
[194] P. Markwick,et al. Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P and a sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridge. , 2003, Biochemistry.
[195] A. McDermott,et al. Expression of human β-defensins in conjunctival epithelium : relevance to dry eye disease , 2003 .
[196] J. Malm,et al. Processing of Seminal Plasma hCAP-18 to ALL-38 by Gastricsin , 2003, Journal of Biological Chemistry.
[197] Y. Lim,et al. α-Defensin 1 (Human Neutrophil Protein 1) as an Antichemotactic Agent for Human Polymorphonuclear Leukocytes , 2003, Antimicrobial Agents and Chemotherapy.
[198] T. Ganz. Faculty Opinions recommendation of Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. , 2003 .
[199] D. Hoover,et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[200] S. Zahler,et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.
[201] Hongxia Zhao. Mode of Action of Antimicrobial Peptides , 2003 .
[202] G. K. Johnson,et al. Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. , 2003, Oral microbiology and immunology.
[203] E. Noga,et al. Piscidins: a novel family of peptide antibiotics from fish. , 2003, Drug news & perspectives.
[204] Michael R. Yeaman,et al. Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.
[205] T. Ng,et al. Isolation of a large thaumatin-like antifungal protein from seeds of the Kweilin chestnut Castanopsis chinensis. , 2003, Biochemical and biophysical research communications.
[206] Jianzhi Zhang,et al. Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. , 2003, Nucleic acids research.
[207] V. Smith,et al. Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss. , 2002, The Biochemical journal.
[208] J. Schröder,et al. RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin* , 2002, The Journal of Biological Chemistry.
[209] M. Salton,et al. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. , 2002, The Journal of antimicrobial chemotherapy.
[210] D. Combs,et al. Albumin affinity tags increase peptide half-life in vivo. , 2002, Bioorganic & medicinal chemistry letters.
[211] R. Hancock,et al. The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.
[212] A. Schmidtchen,et al. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 , 2002, Molecular microbiology.
[213] Min Zhang,et al. Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins* , 2002, The Journal of Biological Chemistry.
[214] P. Nibbering,et al. Expression of β‐defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells , 2002 .
[215] Norbert Sewald,et al. Peptides: Chemistry and Biology: Sewald: Peptides E-BK , 2002 .
[216] M. Goodman,et al. New reagents, reactions, and peptidomimetics for drug design. , 2002, Biopolymers.
[217] Tae Gwan Park,et al. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. , 2002, Biomaterials.
[218] C. Soto,et al. Converting a peptide into a drug: strategies to improve stability and bioavailability. , 2002, Current medicinal chemistry.
[219] Andreas Peschel,et al. How do bacteria resist human antimicrobial peptides? , 2002, Trends in microbiology.
[220] Jürg Müller,et al. Cupiennin 1, a New Family of Highly Basic Antimicrobial Peptides in the Venom of the Spider Cupiennius salei(Ctenidae)* , 2002, The Journal of Biological Chemistry.
[221] O. Levy,et al. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[222] R. Hancock,et al. Sublethal Concentrations of Pleurocidin-Derived Antimicrobial Peptides Inhibit Macromolecular Synthesis in Escherichia coli , 2002, Antimicrobial Agents and Chemotherapy.
[223] O. Yang,et al. Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[224] Jesse D. Walters,et al. Discovery of five conserved β-defensin gene clusters using a computational search strategy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[225] M. Dathe,et al. General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. , 2002, Biochimica et biophysica acta.
[226] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[227] T. Ganz,et al. Cathelicidins: a family of endogenous antimicrobial peptides , 2002, Current opinion in hematology.
[228] Nikolaus Blin,et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands , 2001, Nature Immunology.
[229] A. Tossi,et al. Amphipathic alpha helical antimicrobial peptides. , 2001, European journal of biochemistry.
[230] A. Schmidtchen,et al. Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers. , 2001, Acta dermato-venereologica.
[231] Alessandro Tossi,et al. Amphipathic α helical antimicrobial peptides. , 2001 .
[232] R. Hancock,et al. Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.
[233] R. Hancock,et al. Interaction of Cationic Antimicrobial Peptides with Model Membranes* , 2001, The Journal of Biological Chemistry.
[234] I. Nagaoka,et al. Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-α by Blocking the Binding of LPS to CD14+ Cells1 , 2001, The Journal of Immunology.
[235] Michael Bienert,et al. Optimization of the antimicrobial activity of magainin peptides by modification of charge , 2001, FEBS letters.
[236] J. Calafat,et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.
[237] J. Rossier,et al. Ponericins, New Antibacterial and Insecticidal Peptides from the Venom of the Ant Pachycondyla goeldii * , 2001, The Journal of Biological Chemistry.
[238] Michael Otto,et al. Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.
[239] P. Friden,et al. Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5 , 2001, Antimicrobial Agents and Chemotherapy.
[240] Arie V. Nieuw Amerongen,et al. Antimicrobial Peptides: Properties and Applicability , 2001, Biological chemistry.
[241] S. Lovas,et al. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.
[242] C. Vogelmeier,et al. Rhesus Monkey (Macaca mulatta) Mucosal Antimicrobial Peptides Are Close Homologues of Human Molecules , 2001, Clinical Diagnostic Laboratory Immunology.
[243] R. Lanot,et al. Insect Immunity , 2001, The Journal of Biological Chemistry.
[244] A. Schmidtchen,et al. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial α‐defensin , 2001, Molecular microbiology.
[245] R. Hancock,et al. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. , 2000, Biochemistry.
[246] H. Jörnvall,et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. , 2000, Blood.
[247] M. Welsh,et al. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[248] S. Lovas,et al. Interaction between heat shock proteins and antimicrobial peptides. , 2000, Biochemistry.
[249] R I Lehrer,et al. Crystallization of antimicrobial pores in membranes: magainin and protegrin. , 2000, Biophysical journal.
[250] K. Matsuzaki,et al. Polar Angle as a Determinant of Amphipathic α-Helix-Lipid Interactions: A Model Peptide Study , 2000 .
[251] B. Finlay,et al. An α-Helical Cationic Antimicrobial Peptide Selectively Modulates Macrophage Responses to Lipopolysaccharide and Directly Alters Macrophage Gene Expression1 , 2000, The Journal of Immunology.
[252] R. Hancock. Cationic antimicrobial peptides: towards clinical applications , 2000, Expert opinion on investigational drugs.
[253] P. Bulet,et al. Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda) , 2000, Cellular and Molecular Life Sciences CMLS.
[254] William C. Parks,et al. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria , 2000, Nature Immunology.
[255] H. Lilja,et al. The Human Cationic Antimicrobial Protein (hCAP-18) Is Expressed in the Epithelium of Human Epididymis, Is Present in Seminal Plasma at High Concentrations, and Is Attached to Spermatozoa , 2000, Infection and Immunity.
[256] A. Angelova,et al. Interaction of the peptide antibiotic alamethicin with bilayer- and non-bilayer-forming lipids: influence of increasing alamethicin concentration on the lipids supramolecular structures. , 2000, Archives of biochemistry and biophysics.
[257] H. G. Boman. Innate immunity and the normal microflora , 2000, Immunological reviews.
[258] R. Hancock,et al. Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein1 , 2000, The Journal of Immunology.
[259] R. Colman,et al. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. , 2000, Blood.
[260] K. Matsuzaki. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.
[261] R. Nagaraj,et al. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. , 1999, Biochimica et biophysica acta.
[262] C. Toniolo,et al. The antimicrobial peptide trichogin and its interaction with phospholipid membranes. , 1999, European journal of biochemistry.
[263] James M. Wilson,et al. Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide , 1999, Infection and Immunity.
[264] Christopher J. Miller,et al. Isolation, Characterization, cDNA Cloning, and Antimicrobial Properties of Two Distinct Subfamilies of α-Defensins from Rhesus Macaque Leukocytes , 1999, Infection and Immunity.
[265] F C Kafatos,et al. Phylogenetic perspectives in innate immunity. , 1999, Science.
[266] P. Wong,et al. Interaction of tannin with human salivary histatins. , 1999, Journal of agricultural and food chemistry.
[267] M. Lafleur,et al. Nisin promotes the formation of non-lamellar inverted phases in unsaturated phosphatidylethanolamines. , 1999, Biochimica et biophysica acta.
[268] James M. Wilson,et al. The innate immune system in cystic fibrosis lung disease. , 1999, The Journal of clinical investigation.
[269] E. Greenberg,et al. Production of β-defensins by human airway epithelia , 1998 .
[270] P. Balaram,et al. Omega amino acids in peptide design: incorporation into helices. , 1998, Biopolymers.
[271] J. Larrick,et al. Evaluation of Antimicrobial and Lipopolysaccharide-Neutralizing Effects of a Synthetic CAP18 Fragment against Pseudomonas aeruginosa in a Mouse Model , 1998, Antimicrobial Agents and Chemotherapy.
[272] W. Müller,et al. Sarcophytolide: a new neuroprotective compound from the soft coral Sarcophyton glaucum. , 1998, Toxicology.
[273] C. B. Park,et al. Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization. , 1998, Biochimica et biophysica acta.
[274] Samuel I. Miller,et al. Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides , 1998, Cell.
[275] E. Pauwels,et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. , 1998, The Journal of clinical investigation.
[276] J. Bland,et al. Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin. , 1998, Medical mycology.
[277] V. Bafna,et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. , 1998, The Journal of clinical investigation.
[278] Alan J. Waring,et al. Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.
[279] P. H. Hansen,et al. Secretory expression of human albumin domains in Saccharomyces cerevisiae and their binding of myristic acid and an acylated insulin analogue. , 1998, Protein expression and purification.
[280] T. Cleveland,et al. Fungicidal properties, sterol binding, and proteolytic resistance of the synthetic peptide D4E1. , 1998, Canadian journal of microbiology.
[281] M. Heinzelmann,et al. Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation. , 1998, Journal of immunology.
[282] R. Lehrer,et al. Activity of Protegrins against Yeast-PhaseCandida albicans , 1998, Infection and Immunity.
[283] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[284] C. Subbalakshmi,et al. Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.
[285] James M. Wilson,et al. Mouse β-Defensin 1 Is a Salt-Sensitive Antimicrobial Peptide Present in Epithelia of the Lung and Urogenital Tract , 1998, Infection and Immunity.
[286] K. Berndt,et al. Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37* , 1998, The Journal of Biological Chemistry.
[287] R. Hancock,et al. Cationic peptides: a new source of antibiotics. , 1998, Trends in biotechnology.
[288] A. Salyers,et al. Why are antibiotic resistance genes so resistant to elimination? , 1997, Antimicrobial agents and chemotherapy.
[289] R. Epand,et al. Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. , 1997, Biochemistry.
[290] P. Axelsen,et al. The concentration-dependent membrane activity of cecropin A. , 1997, Biochemistry.
[291] Y. Kirino,et al. Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. , 1997, Biochemistry.
[292] R. Murali,et al. Therapeutic peptides and peptidomimetics. , 1997, Current opinion in biotechnology.
[293] H. Heng,et al. The human β-defensin-1 and α-defensins are encoded by adjacent genes : Two peptide families with differing disulfide topology share a common ancestry , 1997 .
[294] H. Wigzell,et al. The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.
[295] Jiang Hong,et al. A Repertoire of Novel Antibacterial Diastereomeric Peptides with Selective Cytolytic Activity* , 1997, The Journal of Biological Chemistry.
[296] G. Diamond,et al. Isolation and Characterization of Pleurocidin, an Antimicrobial Peptide in the Skin Secretions of Winter Flounder* , 1997, The Journal of Biological Chemistry.
[297] M. Dathe,et al. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides , 1997, FEBS letters.
[298] J. Gesell,et al. Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an α-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution , 1997, Journal of biomolecular NMR.
[299] W. Shafer,et al. Protegrin structure and activity against Neisseria gonorrhoeae , 1997, Infection and immunity.
[300] P. Fehlbaum,et al. Characterization of Novel Cysteine-rich Antimicrobial Peptides from Scorpion Blood* , 1996, The Journal of Biological Chemistry.
[301] L. Bagella,et al. Biological Characterization of Two Novel Cathelicidin-derived Peptides and Identification of Structural Requirements for Their Antimicrobial and Cell Lytic Activities* , 1996, The Journal of Biological Chemistry.
[302] R. Prasad,et al. Lipids of Pathogenic Fungi , 1996 .
[303] London Wc,et al. De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity , 1996 .
[304] L. Thim,et al. Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation‐enhancing LPS‐induced cytokine release from monocytes , 1996, FEBS letters.
[305] A. Ouellette,et al. Positional specificity of defensin gene expression reveals Paneth cell heterogeneity in mouse small intestine. , 1996, The American journal of physiology.
[306] D. Taub,et al. Identification of Defensin-1, Defensin-2, and CAP37/Azurocidin as T-cell Chemoattractant Proteins Released from Interleukin-8-stimulated Neutrophils (*) , 1996, The Journal of Biological Chemistry.
[307] S. Ludtke,et al. Membrane thinning caused by magainin 2. , 1995, Biochemistry.
[308] Domenico Romeo,et al. Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.
[309] A. Bennick,et al. Identification of histatins as tannin-binding proteins in human saliva. , 1995, The Biochemical journal.
[310] S. Ludtke,et al. X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. , 1995, Biophysical journal.
[311] A. Otaka,et al. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. , 1995, Chemical & pharmaceutical bulletin.
[312] T. Saito,et al. A novel big defensin identified in horseshoe crab hemocytes: isolation, amino acid sequence, and antibacterial activity. , 1995, Journal of biochemistry.
[313] G M Anantharamaiah,et al. Molecular basis for prokaryotic specificity of magainin-induced lysis. , 1995, Biochemistry.
[314] J. Larrick,et al. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein , 1995, Infection and immunity.
[315] M. Saito,et al. Three conserved glycine residues in valine activation of gramicidin S synthetase 2 from Bacillus brevis. , 1995, Journal of biochemistry.
[316] Y. Shai,et al. The alpha-5 segment of Bacillus thuringiensis delta-endotoxin: in vitro activity, ion channel formation and molecular modelling. , 1994, The Biochemical journal.
[317] M. V. Van Regenmortel,et al. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[318] R. Gennaro,et al. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes , 1994, FEBS letters.
[319] K. Sugiyama. Anti-lipopolysaccharide activity of histatins, peptides from human saliva , 1993, Experientia.
[320] M. Nakazato,et al. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. , 1993, Biochemical and biophysical research communications.
[321] R. Lehrer,et al. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins , 1993, FEBS letters.
[322] H. G. Boman,et al. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.
[323] D. Desiderio,et al. Structure-function studies of amphiphilic antibacterial peptides. , 1993, Journal of medicinal chemistry.
[324] Douglas E. Jones,et al. Defensin‐6 mRNA in human Paneth cells: implications for antimicrobia peptides in host defense of the human bowel , 1993, FEBS letters.
[325] R A Houghten,et al. Design of model amphipathic peptides having potent antimicrobial activities. , 1992, Biochemistry.
[326] J. J. Pollock,et al. Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva. , 1992, Oral microbiology and immunology.
[327] M. Zasloff. Antibiotic peptides as mediators of innate immunity , 1992, Current Biology.
[328] Y. Shai,et al. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. , 1991, The Journal of biological chemistry.
[329] P. Engstrom,et al. Attacin, an antibacterial protein from Hyalophora cecropia, inhibits synthesis of outer membrane proteins in Escherichia coli by interfering with omp gene transcription , 1991, Infection and immunity.
[330] C. Bucana,et al. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. , 1991, Cancer research.
[331] N. Fujii,et al. Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. , 1991, Biochimica et biophysica acta.
[332] T. Ganz,et al. Defensins , 1990, European journal of haematology.
[333] T. Ganz,et al. Monocyte-chemotactic activity of defensins from human neutrophils. , 1989, The Journal of clinical investigation.
[334] T. Mohandas,et al. Assignment of defensin gene(s) to human chromosome 8p23. , 1989, Genomics.
[335] E. Saitoh,et al. Tissue Distribution of RNAs for Cystatins, Histatins, Statherin, and Proline-rich Salivary Proteins in Humans and Macaques , 1989, Journal of dental research.
[336] E. Azen,et al. Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2). , 1989, Biochemical and biophysical research communications.
[337] M. Zasloff,et al. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[338] S. Levitz,et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. , 1988, The Journal of biological chemistry.
[339] R I Lehrer,et al. Direct inactivation of viruses by human granulocyte defensins , 1986, Journal of virology.
[340] R I Lehrer,et al. Primary structures of three human neutrophil defensins. , 1985, The Journal of clinical investigation.
[341] T. Ganz,et al. DEFENSINS: NATURAL PEPTIDE ANTIBIOTICS IN HUMAN NEUTROPHILS , 1986 .
[342] S. Matsunaga,et al. Bioactive marine metabolites, IV. Isolation and the amino acid composition of discodermin A, an antimicrobial peptide, from the marine sponge Discodermia kiiensis. , 1985, Journal of natural products.
[343] K. Moon,et al. Complete primary structure of human C4a anaphylatoxin. , 1981, The Journal of biological chemistry.
[344] D. Hultmark,et al. Sequence and specificity of two antibacterial proteins involved in insect immunity , 1981, Nature.
[345] H Lecar,et al. Electrically gated ionic channels in lipid bilayers , 1977, Quarterly Reviews of Biophysics.
[346] R. Peters,et al. Distribution of lipids in cytoplasmic and outer membranes of Escherichia coli K12. , 1976, Biochimica et biophysica acta.
[347] S. Baudner,et al. [Human serum proteins with high affinity to carboxymethylcellulose. II. Physico-chemical and immunological characterization of a histidine-rich 3,8S- 2 -glycoportein (CM-protein I)]. , 1972, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[348] H. Haupt,et al. [Human serum proteins with high affinity for carboxymethylcellulose. I. Isolation of lysozyme, C1q and 2 hitherto unknown -globulins]. , 1972, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[349] B. Rasmuson,et al. Inducible Antibacterial Defence System in Drosophila , 1972, Nature.
[350] J. Gier,et al. Chages in permeability of Staphylococcus aureus and derived liposomes with varying lipid composition. , 1972, Biochimica et biophysica acta.
[351] G. de Haas,et al. Synthetic and structural investigations on 3-phosphatidyl-1'-(3'-O-L-lysyl)glycerol. , 1967, Biochemistry.
[352] H. I. Zeya,et al. Cationic Proteins of Polymorphonuclear Leukocyte Lysosomes II. Composition, Properties, and Mechanism of Antibacterial Action , 1966, Journal of bacteriology.
[353] H. I. Zeya,et al. Cationic Proteins of Polymorphonuclear Leukocyte Lysosomes I. Resolution of Antibacterial and Enzymatic Activities , 1966, Journal of bacteriology.
[354] H. I. Zeya,et al. Antibacterial and Enzymic Basic Proteins from Leukocyte Lysosomes: Separation and Identification , 1963, Science.
[355] A. Nixon. Therapeutic Peptides , 2014, Methods in Molecular Biology.
[356] L. Hazlett,et al. Defensins in innate immunity , 2010, Cell and Tissue Research.
[357] G. Norbert,et al. Defensin-like antifungal proteins secreted by filamentous fungi , 2010 .
[358] T. Panavas,et al. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. , 2009, Methods in molecular biology.
[359] R. Epand,et al. Lipid domains in bacterial membranes and the action of antimicrobial agents. , 2009, Biochimica et biophysica acta.
[360] A. Cole,et al. Antimicrobial peptides in innate immune responses. , 2008, Contributions to microbiology.
[361] Artem Cherkasov,et al. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction. , 2008, Methods in molecular biology.
[362] A. Schmidtchen,et al. An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[363] G. Pabst,et al. Chapter Five Liposome-Based Biomembrane Mimetic Systems: Implications for Lipid–Peptide Interactions , 2008 .
[364] R. Litaker,et al. Antimicrobial peptides derived from hemoglobin are expressed in epithelium of channel catfish (Ictalurus punctatus, Rafinesque). , 2008, Developmental and comparative immunology.
[365] W. Driscoll,et al. alpha-Amidated peptides: approaches for analysis. , 2008, Methods in molecular biology.
[366] Chun Xing Li,et al. Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. , 2008, Developmental and comparative immunology.
[367] A. Schmidtchen,et al. Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. , 2007, Biophysical journal.
[368] P. Sautière,et al. Hedistin: A novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor. , 2007, Developmental and comparative immunology.
[369] P. Yu,et al. Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins. , 2006, International journal of antimicrobial agents.
[370] V. Nizet. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. , 2006, Current issues in molecular biology.
[371] A. Bayer,et al. Advances in antimicrobial peptide immunobiology , 2006, Biopolymers.
[372] R. Hancock,et al. Immunomodulatory Properties of Defensins and Cathelicidins , 2006, Current topics in microbiology and immunology.
[373] I. Nagaoka,et al. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. , 2006, Critical reviews in immunology.
[374] M. Otto,et al. Bacterial evasion of antimicrobial peptides by biofilm formation. , 2006, Current topics in microbiology and immunology.
[375] D. Scheidegger,et al. Peptide drugs, overcoming the challenges, a growing business , 2006 .
[376] M. Verlander,et al. Are low-priced peptides affordable? , 2006 .
[377] W. Shafer. Antimicrobial peptides and human disease , 2006 .
[378] M. Yeaman,et al. Immunocontinuum: perspectives in antimicrobial peptide mechanisms of action and resistance. , 2005, Protein and peptide letters.
[379] D. Phoenix,et al. Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships. , 2005, Protein and peptide letters.
[380] D. Phoenix,et al. Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion? , 2005, Protein and peptide letters.
[381] M. A. Rothschild,et al. Serum albumin , 2005, The American Journal of Digestive Diseases.
[382] H. Vogel,et al. Lactoferricin , 2005, Cellular and Molecular Life Sciences.
[383] D. Phoenix,et al. Are Oblique Orientated α-Helices Used by Antimicrobial Peptides for Membrane Invasion? , 2005 .
[384] D. Phoenix,et al. Amphiphilic α-Helical Antimicrobial Peptides and Their Structure / Function Relationships , 2005 .
[385] Naoshi Ohta,et al. Biology of lysenin, a protein in the coelomic fluid of the earthworm Eisenia foetida. , 2004, International review of cytology.
[386] M. Sansom. Alamethicin and related peptaibols — model ion channels , 2004, European Biophysics Journal.
[387] P. F. Almeida,et al. Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides. , 2004, Biochemistry.
[388] Zhe Wang,et al. APD: the Antimicrobial Peptide Database , 2004, Nucleic Acids Res..
[389] Robert Bals,et al. Antimicrobial Peptides , 2012, Drugs.
[390] Y. Lim,et al. Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes. , 2003, Antimicrobial agents and chemotherapy.
[391] A. McDermott,et al. Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. , 2003, Investigative ophthalmology & visual science.
[392] A. Schmidtchen,et al. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. , 2003, Microbial pathogenesis.
[393] B. Thomma,et al. Plant defensins , 2002, Planta.
[394] Robert E W Hancock,et al. Role of membranes in the activities of antimicrobial cationic peptides. , 2002, FEMS microbiology letters.
[395] P. Nibbering,et al. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. , 2002, Immunology.
[396] Y. Shai,et al. Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.
[397] M. Heinzelmann,et al. Heparin binding protein (CAP37) differentially modulates endotoxin-induced cytokine production. , 2001, International journal of surgical investigation.
[398] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[399] I. Nagaoka,et al. Cathelicidin Family of Antibacterial Peptides , 2001 .
[400] Alessandro Tossi,et al. Amphipathic, α‐helical antimicrobial peptides , 2000 .
[401] R. Hancock,et al. Cationic antimicrobial peptides and their multifunctional role in the immune system. , 2000, Critical reviews in immunology.
[402] M. Selsted,et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. , 2000, Nature immunology.
[403] A. Griffioen,et al. Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. , 2000, Blood.
[404] J. Fiddes,et al. Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. , 2000, Biopolymers.
[405] K. Matsuzaki,et al. Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study. , 2000, Biophysical journal.
[406] A. Hughes,et al. Evolutionary diversification of the mammalian defensins , 1999, Cellular and Molecular Life Sciences CMLS.
[407] R. Sato,et al. Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa. , 1999, Archives of insect biochemistry and physiology.
[408] A. Rao,et al. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. , 1999, Archives of biochemistry and biophysics.
[409] Gupta,et al. The concentration-dependent membrane activity of cecropin A , 1999, Biochemistry.
[410] E. Greenberg,et al. Production of beta-defensins by human airway epithelia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[411] L. Bobek,et al. Human salivary histatins: promising anti-fungal therapeutic agents. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[412] R. Hodges,et al. Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. , 1998, The journal of peptide research : official journal of the American Peptide Society.
[413] H. Heng,et al. The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. , 1997, Genomics.
[414] S. Bishop,et al. De novo antimicrobial peptides with low mammalian cell toxicity. , 1996, Journal of medicinal chemistry.
[415] R. Houghten,et al. Generation and use of nonsupport-bound peptide and peptidomimetic combinatorial libraries. , 1996, Methods in enzymology.
[416] S. Pillai,et al. Innate immunity. , 1996, Current opinion in immunology.
[417] H. G. Boman,et al. Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.
[418] R I Lehrer,et al. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. , 1993, Annual review of immunology.
[419] S. Shizukuishi,et al. Inhibitory effects of synthetic histidine-rich peptides on haemagglutination by Bacteroides gingivalis 381. , 1990, Archives of oral biology.
[420] P. Elsbach. Antibiotics from within: antibacterials from human and animal sources. , 1990, Trends in biotechnology.
[421] T. Hugli. Structure and function of C3a anaphylatoxin. , 1990, Current topics in microbiology and immunology.
[422] Giorgio Piccaluga,et al. X-ray diffraction study of a , 1977 .
[423] H. Haupt,et al. Humanserumproteine mit hoher Affinität zu Carboxymethylcellulose, I, Isolierung von Lysozym, C1q und zwei bisher unbekannten α-Globulinen , 1972 .